PMC:7589163 / 86838-87187 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T380","span":{"begin":104,"end":117},"obj":"Body_part"},{"id":"T381","span":{"begin":236,"end":249},"obj":"Body_part"}],"attributes":[{"id":"A380","pred":"fma_id","subj":"T380","obj":"http://purl.org/sig/ont/fma/fma76497"},{"id":"A381","pred":"fma_id","subj":"T381","obj":"http://purl.org/sig/ont/fma/fma76497"}],"text":"Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor et al., 2006 [214] InfantsRCT DHA (17 mg/100 kcal) Reduced incidence of bronchiolitis/bronchitis in the DHA+ group at 5 months (p = 0.0001), 7 months (p = 0.01), and 9 months (p = 0.01)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T411","span":{"begin":104,"end":117},"obj":"Disease"},{"id":"T412","span":{"begin":118,"end":128},"obj":"Disease"},{"id":"T413","span":{"begin":236,"end":249},"obj":"Disease"},{"id":"T414","span":{"begin":250,"end":260},"obj":"Disease"}],"attributes":[{"id":"A411","pred":"mondo_id","subj":"T411","obj":"http://purl.obolibrary.org/obo/MONDO_0002465"},{"id":"A412","pred":"mondo_id","subj":"T412","obj":"http://purl.obolibrary.org/obo/MONDO_0003781"},{"id":"A413","pred":"mondo_id","subj":"T413","obj":"http://purl.obolibrary.org/obo/MONDO_0002465"},{"id":"A414","pred":"mondo_id","subj":"T414","obj":"http://purl.obolibrary.org/obo/MONDO_0003781"}],"text":"Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor et al., 2006 [214] InfantsRCT DHA (17 mg/100 kcal) Reduced incidence of bronchiolitis/bronchitis in the DHA+ group at 5 months (p = 0.0001), 7 months (p = 0.01), and 9 months (p = 0.01)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T774","span":{"begin":104,"end":117},"obj":"http://purl.obolibrary.org/obo/UBERON_0002186"},{"id":"T775","span":{"begin":236,"end":249},"obj":"http://purl.obolibrary.org/obo/UBERON_0002186"}],"text":"Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor et al., 2006 [214] InfantsRCT DHA (17 mg/100 kcal) Reduced incidence of bronchiolitis/bronchitis in the DHA+ group at 5 months (p = 0.0001), 7 months (p = 0.01), and 9 months (p = 0.01)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T81591","span":{"begin":12,"end":32},"obj":"Chemical"},{"id":"T25653","span":{"begin":28,"end":32},"obj":"Chemical"},{"id":"T63682","span":{"begin":38,"end":54},"obj":"Chemical"},{"id":"T93389","span":{"begin":50,"end":54},"obj":"Chemical"},{"id":"T66388","span":{"begin":193,"end":196},"obj":"Chemical"},{"id":"T59162","span":{"begin":268,"end":271},"obj":"Chemical"},{"id":"T48956","span":{"begin":273,"end":278},"obj":"Chemical"}],"attributes":[{"id":"A42576","pred":"chebi_id","subj":"T81591","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A39983","pred":"chebi_id","subj":"T25653","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A68253","pred":"chebi_id","subj":"T63682","obj":"http://purl.obolibrary.org/obo/CHEBI_15843"},{"id":"A92818","pred":"chebi_id","subj":"T93389","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A16094","pred":"chebi_id","subj":"T66388","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A72518","pred":"chebi_id","subj":"T66388","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A62910","pred":"chebi_id","subj":"T66388","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A94900","pred":"chebi_id","subj":"T66388","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A62723","pred":"chebi_id","subj":"T59162","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A17793","pred":"chebi_id","subj":"T59162","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A64677","pred":"chebi_id","subj":"T59162","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A99134","pred":"chebi_id","subj":"T59162","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A19092","pred":"chebi_id","subj":"T48956","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor et al., 2006 [214] InfantsRCT DHA (17 mg/100 kcal) Reduced incidence of bronchiolitis/bronchitis in the DHA+ group at 5 months (p = 0.0001), 7 months (p = 0.01), and 9 months (p = 0.01)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T255","span":{"begin":104,"end":117},"obj":"Phenotype"},{"id":"T256","span":{"begin":118,"end":128},"obj":"Phenotype"},{"id":"T257","span":{"begin":236,"end":249},"obj":"Phenotype"},{"id":"T258","span":{"begin":250,"end":260},"obj":"Phenotype"}],"attributes":[{"id":"A255","pred":"hp_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/HP_0011950"},{"id":"A256","pred":"hp_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/HP_0012387"},{"id":"A257","pred":"hp_id","subj":"T257","obj":"http://purl.obolibrary.org/obo/HP_0011950"},{"id":"A258","pred":"hp_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/HP_0012387"}],"text":"Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor et al., 2006 [214] InfantsRCT DHA (17 mg/100 kcal) Reduced incidence of bronchiolitis/bronchitis in the DHA+ group at 5 months (p = 0.0001), 7 months (p = 0.01), and 9 months (p = 0.01)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T571","span":{"begin":0,"end":152},"obj":"Sentence"},{"id":"T572","span":{"begin":154,"end":349},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor et al., 2006 [214] InfantsRCT DHA (17 mg/100 kcal) Reduced incidence of bronchiolitis/bronchitis in the DHA+ group at 5 months (p = 0.0001), 7 months (p = 0.01), and 9 months (p = 0.01)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3568","span":{"begin":0,"end":7},"obj":"Species"},{"id":"3590","span":{"begin":12,"end":32},"obj":"Chemical"},{"id":"3591","span":{"begin":38,"end":54},"obj":"Chemical"},{"id":"3592","span":{"begin":193,"end":196},"obj":"Chemical"},{"id":"3593","span":{"begin":268,"end":271},"obj":"Chemical"},{"id":"3628","span":{"begin":104,"end":128},"obj":"Disease"},{"id":"3629","span":{"begin":236,"end":260},"obj":"Disease"}],"attributes":[{"id":"A3568","pred":"tao:has_database_id","subj":"3568","obj":"Tax:9606"},{"id":"A3590","pred":"tao:has_database_id","subj":"3590","obj":"MESH:D004281"},{"id":"A3591","pred":"tao:has_database_id","subj":"3591","obj":"MESH:D016718"},{"id":"A3592","pred":"tao:has_database_id","subj":"3592","obj":"MESH:C027493"},{"id":"A3593","pred":"tao:has_database_id","subj":"3593","obj":"MESH:C027493"},{"id":"A3628","pred":"tao:has_database_id","subj":"3628","obj":"MESH:D001991"},{"id":"A3629","pred":"tao:has_database_id","subj":"3629","obj":"MESH:D001991"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Pastor et al., 2006 [214] InfantsRCT DHA (17 mg/100 kcal) Reduced incidence of bronchiolitis/bronchitis in the DHA+ group at 5 months (p = 0.0001), 7 months (p = 0.01), and 9 months (p = 0.01)"}